Study of Belimumab Administered Subcutaneously to Healthy Subjects
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of this study is to measure the amount of belimumab in the blood when given as an injection under the skin (subcutaneously; SC) and to evaluate the safety and tolerability of multiple injections under the skin in healthy subjects.
Key facts
- Study ID
- NCT01583530
- Run by
- Human Genome Sciences Inc.
- People needed
- 118
- Starts
- 2011-02-01
- Expected to finish
- 2011-09-01
- Last updated by the study team
- 2013-08-07
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Study site — Daytona Beach, Florida, United States
- Study site — Evansville, Indiana, United States
- Study site — Dallas, Texas, United States
- Study site — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.